Aviance Capital Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,000
| Closed | -$341K | – | 251 |
|
|
2023
Q2 | $341K | Hold |
10,000
| – | – | 0.07% | 205 |
|
|
2023
Q1 | $301K | Hold |
10,000
| – | – | 0.07% | 218 |
|
|
2022
Q4 | $282K | Hold |
10,000
| – | – | 0.07% | 233 |
|
|
2022
Q3 | $329K | Buy |
+10,000
| New | +$329K | 0.08% | 198 |
|
|
2021
Q4 | – | Sell |
-3,600
| Closed | -$269K | – | 253 |
|
|
2021
Q3 | $269K | Sell |
3,600
-6,850
| -66% | -$512K | 0.05% | 229 |
|
|
2021
Q2 | $967K | Buy |
10,450
+50
| +0.5% | +$4.63K | 0.17% | 145 |
|
|
2021
Q1 | $923K | Buy |
+10,400
| New | +$923K | 0.18% | 147 |
|